 
                                
                                
                                                                    
                                        
                                            
                                            Market News                                        
                                    
                                                            
                            
                            Why Novo Nordisk’s GLP-1 Growth Is Slowing: Key Insights
                                    Novo Nordisk’s Ozempic is losing ground in the GLP-1 market. What’s behind the slowdown, and can it recover? Dive into...                                
                                
                                
                                
                                            
                                            05/08/2025
                                        
                                        
                                        
                                            
                                            3 views                                        
                                    

